Endonovo Therapeutics new multi-use brace allows site-specific application and promotes ease of use for patients and medical professionals when using the SofPulse device. CEO Alan Collier stated, “As we continue our U.S. market rollout of SofPulse we have been engaged in constant dialogue with medical professionals regarding how to improve the benefits patients receive when using SofPulse. From that dialog, we learned patients and medical practitioners were looking for a specialized brace allowing them to improve the ease of use and application of the SofPulse device. Endonovo Therapeutics in adding an ancillary brace to support and improve ease of use and application, reapplication and site-specific uses of SofPulse is helping speed up patient’s surgical recovery in the hospital or when they get home after their surgical procedures.”
Endonovo CMO Dr. Nev Zubcevik added, “SofPulse is FDA-cleared for reducing the pain and edema after surgery and delivers these benefits for at least eight days after surgery. Developing better, easier and more efficient ways for patients and medical professionals to ensure SofPulse use and reapplication during and after hospital release is an important part of improving the surgical recovery process. Developing secure ways for patients to receive SofPulse benefits after surgical procedures will help with making the SofPulse standard of care for different surgical procedures. The SofPulse has proven track record in reducing the need and amount of opioids prescribed after surgical procedures both in placebo controlled clinical trials as well as in clinical practice. The new multi-use brace designed specifically for the SofPulse will help patients with ease of use and improve delivery of drug-free, opioid reduction benefits for patients postoperatively.”
The specialized Protex brace and hook has been developed and designed by Endonovo Therapeutics and White L.H. Inc.